Débora Lessa's peptide therapy claims need context

What did @deboralessa__ actually say?

Honestly? It is not clear. The transcript from this video is largely incoherent, consisting of disconnected phrases like "I want to feel like I have a couple of legs" and references to someone named Dora wanting her pants. There is no identifiable claim about peptides, dosing, healing, or any health topic. This is not a fact-check of a bold claim. It is a fact-check of noise.

The video falls under the peptide category on FormBlends, which covers compounds like BPC-157, TB-500, and CJC-1295. But nothing in the transcript references any of those compounds by name or effect. Either the auto-transcription failed catastrophically, the audio was too distorted to capture, or this video does not contain the health content the category suggests. Without a legible claim, there is nothing to verify, and that itself is worth documenting.

Does the science back this up?

There is no claim here to test against the literature. So instead, here is what the actual science says about the peptide category this video was filed under, since viewers landing on this content may already believe they heard something meaningful.

BPC-157, one of the most discussed peptides in this space, has shown regenerative effects in rodent models, including tendon repair and gut healing. Sikiric et al. (2018, Current Pharmaceutical Design) reviewed years of preclinical data and found consistent signaling effects on growth hormone receptors and nitric oxide pathways. But human clinical trials remain sparse and unpublished at scale. TB-500, a synthetic fragment of thymosin beta-4, shows similar animal-model promise for tissue repair, but again, controlled human data is limited. GHK-Cu has demonstrated skin regeneration properties in in vitro studies (Pickart et al., 2015, Journal of Aging Research), but that is not the same as proving clinical outcomes in living patients. The gap between animal data and human benefit is real and wide.

What did they get wrong (or right)?

Because the transcript contains no extractable health claims, there is nothing factually wrong to correct in the traditional sense. What is worth flagging is the category mismatch. A video tagged under peptide therapy that delivers no comprehensible peptide information is a problem for a different reason: it contributes to an environment where viewers may assume they absorbed useful health guidance when they did not.

Peptide content on short-form video platforms frequently mixes legitimate recovery science with anecdote, wishful thinking, and occasionally dangerous dosing advice. Viewers who watch a 15-second clip and walk away thinking they understand BPC-157 protocols are more vulnerable to misinformation, not less. If this video was intended to be an informational post and the audio simply did not capture well, that is a production failure with real downstream consequences in a regulated health context. Credit where it is due: at least no dangerous dose was stated.

What should you actually know?

If you found this video while researching peptide therapy, here is what actually matters. Peptides are not a monolith. Each compound has a distinct mechanism, evidence base, and risk profile. Lumping BPC-157 and MK-677 into the same mental bucket because they both get called "peptides" is like grouping aspirin and metformin because they are both pills.

Most peptides discussed in wellness spaces are not FDA-approved drugs. Some, like MK-677 (ibutamoren), are research chemicals with meaningful side effect profiles including insulin resistance and fluid retention (Copinschi et al., 1996, Journal of Clinical Endocrinology and Metabolism). Semax and Selank have Soviet-era clinical data, mostly from Russian journals, that has not been replicated in Western peer-reviewed settings at scale. That does not make them useless, but it does mean the confidence level on efficacy claims should be low.

If a video cannot clearly articulate what a compound does, why you might use it, and what the known risks are, it is not a source worth trusting for health decisions. Consult a licensed provider who works with compounded peptides legally and can review your individual health picture before anything else.